本文選題：間充質(zhì)干細(xì)胞 + 內(nèi)皮前體細(xì)胞　； 參考：《石河子大學(xué)》2015年碩士論文

【摘要】：目的:探索同時從C57BL/6小鼠骨髓分離培養(yǎng)間充質(zhì)干細(xì)胞(MSCs)與內(nèi)皮前體細(xì)胞(EPCs)并對其鑒定的方法,并探討EPCs條件培養(yǎng)基及EPCs在非接觸共培養(yǎng)體系里對MSCs增殖的影響。方法:1.小鼠骨髓細(xì)胞經(jīng)改良差時貼壁法分離,以48 h為時間點,48 h內(nèi)貼壁細(xì)胞傳至3代后行成骨、成軟骨、成脂分化誘導(dǎo)實驗,流式細(xì)胞術(shù)(FCM)檢測其表面標(biāo)記;48 h后收集未貼壁細(xì)胞,傳至3代后行血管形成實驗,傳至5代后行CD31免疫熒光細(xì)胞染色實驗,FCM檢測其表面標(biāo)記。2.將MSCs分為0 EPC-CM組(采用LG-DMEM培養(yǎng))、50%EPC-CM組(采用50%EPC-CM+50%LG-DMEM培養(yǎng))和100%EPC-CM組(采用100%EPC-CM培養(yǎng))。3.取第3代MSCs和EPCs,按1:1的細(xì)胞比例接種入Transwell共培養(yǎng)系統(tǒng)中,以下室接種MSCs,上室接種EPCs為實驗組。同時設(shè)置相同密度單純MSCs接種于下室為對照組。采用MTT比色法和Ed U熒光標(biāo)記法檢測MSCs對EPCs增殖能力的影響。結(jié)果:1.FCM檢測第3代MSCs高表達(dá)Sca-1、CD29,低表達(dá)CD45、CD11b;經(jīng)誘導(dǎo)可向成骨、成軟骨、成脂方向分化。FCM檢測第3代EPCs高表達(dá)CD34、CD133和VEGFR2;在鋪有基質(zhì)膠的96孔培養(yǎng)板中可形成血管樣結(jié)構(gòu)。第5代48 h后貼壁細(xì)胞特異性表面抗原CD31呈陽性表達(dá)。2.MTT比色法結(jié)果顯示與對照組相比較,50%EPC-CM組和100%EPC-CM組MSCs增殖能力明顯增強,且呈濃度依賴性(P0.05)。3.MTT比色法和Ed U熒光標(biāo)記法結(jié)果顯示與對照組相比較,實驗組MSCs的增殖能力在72 h后顯著增強(P0.05);處于DNA合成期的細(xì)胞比例也顯著增多(P0.01)。結(jié)論:利用差速貼壁法可同時分離純化擴增MSCs和EPCs,EPC-CM能促進MSCs的增殖,EPCs在與MSCs非接觸共培養(yǎng)時能促進MSCs的增殖。
[Abstract]:Aim: to explore the methods of simultaneous isolation and identification of mesenchymal stem cells (MSCs) and endothelial progenitor cells (EPCs) from C57BL / 6 mouse bone marrow, and to investigate the effects of EPCs conditioned medium and EPCs on the proliferation of MSCs in non-contact co-culture system. Method 1: 1. Mouse bone marrow cells were separated by modified delayed adhesion method. The adherent cells were transferred to the third passage within 48 h and then osteoblast, cartilage and adipogenic differentiation were induced. Flow cytometry (FCM) was used to detect the surface labeling of the cells and collect unattached cells 48 h later. Angiogenesis was performed after 3 passage and CD31 immunofluorescence cell staining was performed after 5 passage. FCM was used to detect its surface marker. MSCs were divided into 0 EPC-CM group (cultured with LG-DMEM) and 50 EPC-CM group (50 EPC-CM 50 LG-DMEM culture) and 100 EPC-CM group (100 EPC-CM culture). The third passage MSCs and EPCswere inoculated into Transwell co-culture system according to the proportion of cells at 1:1. The following cells were inoculated with MSCs and EPCs were inoculated as experimental group. At the same time, the same density of simple MSCs inoculated in the lower chamber as the control group. The effects of MSCs on proliferation of EPCs were detected by MTT colorimetry and Ed U fluorescence labeling. Results: 1. FCM detected the overexpression of Sca-1G CD29 and low expression of CD45-CD11b in the third generation of MSCs, and then induced osteogenesis, cartilage formation, adipogenic differentiation. FCM was used to detect the high expression of CD34, CD133 and VEGFR2 in the third generation of EPCs, and vascular like structure could be formed in the 96-well culture plate covered with matrix glue. The positive expression of CD31 on adherent cells was observed 48 h after the fifth passage. 2. MTT colorimetric assay showed that the proliferation of MSCs in EPC-CM group was significantly higher than that in EPC-CM group and EPC-CM group, and the proliferation ability of MSCs in EPC-CM group was significantly higher than that in EPC-CM group. In a dose-dependent manner (P0.05). 3. MTT colorimetric assay and Ed U fluorescence labeling method showed that compared with the control group, the proliferation ability of MSCs in the experimental group was significantly increased after 72 h (P0.05), and the proportion of MSCs in DNA synthesis phase was also significantly increased (P0.01). Conclusion: MSCs and EPC-CM can be separated and purified simultaneously by differential adherent method. EPCs can promote the proliferation of MSCs when they are not in contact with MSCs.
【學(xué)位授予單位】：石河子大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2015
【分類號】：R738.1

【共引文獻(xiàn)】

相關(guān)博士學(xué)位論文 前10條

1 陳冠豪;黃芪注射液對肺癌小鼠模型作用機制初探[D];山東中醫(yī)藥大學(xué);2010年

2 陳志芬;人白細(xì)胞介素15與18協(xié)同作用腫瘤浸潤淋巴細(xì)胞對結(jié)腸癌細(xì)胞殺傷功能的研究[D];武漢大學(xué);2010年

3 郭鵬德;腦膠質(zhì)瘤不同病理分級的整合素 α_vβ_3表達(dá)與~(99m)Tc-3PRGD_2顯像的相關(guān)性研究[D];吉林大學(xué);2011年

4 吳飛;性激素對子宮內(nèi)膜癌細(xì)胞增殖、侵襲、凋亡的影響及術(shù)后HRT安全性循證醫(yī)學(xué)分析[D];吉林大學(xué);2011年

5 朱輝;新疆維吾爾族食管鱗癌蛋白質(zhì)圖譜研究[D];新疆醫(yī)科大學(xué);2011年

6 陳麗;表沒食子兒茶素沒食子酸酯在肝癌治療中的自噬藥理學(xué)機制研究[D];廣西醫(yī)科大學(xué);2012年

7 樓建軍;抑癌基因單核苷酸多態(tài)性與鼻咽癌遺傳易感性研究[D];廣西醫(yī)科大學(xué);2012年

8 吳慧;cox-2表達(dá)與食管鱗狀細(xì)胞癌放射敏感性的基礎(chǔ)與臨床研究[D];鄭州大學(xué);2012年

9 鄭國寶;抑癌基因PTEN在大腸癌中的表達(dá)及其意義[D];第二軍醫(yī)大學(xué);2002年

10 王芬;晚期肺癌的中醫(yī)證候研究[D];北京中醫(yī)藥大學(xué);2003年

，

本文編號：2099024